fashion -WSS

fashion

author：Wikipedia 2025-10-01 22:50:43 - browse：96767

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： How the political right came to back psychedelics to treat trauma

WSS

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Retired US general questions alleged Putin, Prigozhin meeting

Study finds gene variants tied to breast cancer risk in Black women

Reports of telehealth's death have been greatly exaggerated

NIH fellows want a pay raise. Will that mean less money for grants?

Reports of telehealth's death have been greatly exaggerated

entertainment

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Charles Manson follower Leslie Van Houten released from prison after 53 years

Hepatitis C has a cure — but many Americans still lack access to it

Retired US general questions alleged Putin, Prigozhin meeting

Sports medicine is finally prioritizing gender equality

Cue Health, Covid

After affirmative action ruling, medical educators look to 'holistic review'

Elizabeth Holmes on track for early release from her 11

Walensky prepares to leave CDC — and Congress — behind

Living with Fabry disease, a condition that causes chronic pain

focus

Fentanyl is making it harder to start addiction treatment

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

N.Y. state detects polio case, first in the U.S. since 2013

Beach reads and more: STAT's 2023 summer book list

Study finds gene variants tied to breast cancer risk in Black women

New research casts further doubt on a common procedure used with IVF

hotspot

Wikipedia

focus

focus